Catherex's Acquisition

Catherex was acquired by Amgen on December 21, 2015.

Catherex, a spin-off of Medigene, is a clinical stage immunotherapy company that focuses on the development of T-cell therapy platforms for the treatment of cancer.…

Articles about Catherex's Acquisition: